Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Noble Romans (NROM) Cash & Equivalents (2016 - 2025)

Noble Romans (NROM) has 15 years of Cash & Equivalents data on record, last reported at $719500.0 in Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 30.47% year-over-year to $719500.0; the TTM value through Sep 2025 reached $719500.0, up 30.47%, while the annual FY2024 figure was $710227.0, 18.58% down from the prior year.
  • Cash & Equivalents reached $719500.0 in Q3 2025 per NROM's latest filing, up from $635629.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $2.0 million in Q2 2021 and bottomed at $463283.0 in Q1 2023.
  • Average Cash & Equivalents over 5 years is $942727.5, with a median of $785522.0 recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: plummeted 58.48% in 2022, then surged 151.48% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $1.3 million in 2021, then plummeted by 37.83% to $785522.0 in 2022, then increased by 11.05% to $872335.0 in 2023, then fell by 18.58% to $710227.0 in 2024, then grew by 1.31% to $719500.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $719500.0 in Q3 2025, $635629.0 in Q2 2025, and $564637.0 in Q1 2025.